|
市場調査レポート
商品コード
1384962
排卵検査キットの世界市場規模、シェア、産業動向分析レポート:製品別、流通経路別、地域別展望と予測、2023年~2030年Global Ovulation Testing Kits Market Size, Share & Industry Trends Analysis Report By Product (Urine Ovulation Test, Digital Ovulation Test, and Saliva Ovulation Test), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
排卵検査キットの世界市場規模、シェア、産業動向分析レポート:製品別、流通経路別、地域別展望と予測、2023年~2030年 |
出版日: 2023年10月31日
発行: KBV Research
ページ情報: 英文 280 Pages
納期: 即納可能
![]() |
排卵検査キットの市場規模は、予測期間中にCAGR 6.4%で成長し、2030年には37億米ドルに達すると予測されます。2022年の市場規模は5億691万2,700個となり、4.8%の成長を遂げる(2019年~2022年)。
パンデミックの最も大きな影響の1つは、排卵検査キットを含む家庭用医療製品の需要が急増したことです。封鎖や規制により、多くの個人がヘルスケア施設、クリニック、薬局への受診を制限しようとしました。そのため、排卵検査キットを含む在宅ヘルスケア・ソリューションへの嗜好が高まっています。その結果、排卵検査キットの市場は著しく売上を伸ばしました。一方、積極的に妊娠を試みる人々にとっては、パンデミック中に成功の可能性を最大化することの重要性が高まったため、排卵検査キットの使用が増加しました。
しかし、偽陽性(排卵が起こっていないのに排卵を示す)や偽陰性(LHサージが起こっているのに検出できない)といった不正確な結果は、使用者の混乱やフラストレーションにつながります。このような不正確さは家族計画への取り組みに影響を及ぼし、消費者の懐疑心を助長する可能性があります。排卵検査キットの品質と一貫性は、同じブランドでも、また同じブランドでも変わることがあります。一貫性のない結果は、これらの製品の評判を損ない、繰り返し購入することを妨げる可能性があります。使用者が必ずしも説明書に正しく従わないこともあり、不正確な結果につながることもあります。メーカーは、明確で詳細な説明書を提供することで、潜在的なユーザーエラーに対処しなければならないです。しかし、ユーザーが一貫してこれらの指示に従うことを保証することは、依然として課題です。
製品の展望
製品別では、市場は尿排卵検査キット、デジタル排卵検査キット、唾液排卵検査キットに区分されます。2022年の市場では、デジタル排卵検査キットが大きな収益シェアを獲得しました。デジタル排卵検査キットの出現は、新興企業に確固たる基盤を提供し、市場での存在感を確立するのに役立つと予想されます。一部のデジタル排卵検査キットにはメモリが内蔵されていたり、スマートフォンのアプリに接続できるようになっていたりするため、ユーザーは受胎能力を長期にわたって追跡したり、月経周期に関する洞察を得たりすることができます。デジタルキットのこうした機能は、こうした革新的なキットの需要を高めると予想されます。さらに、進化するヘルスケア規制の状況は、新規参入者がこうした機会にアクセスするための好条件を生み出しています。
流通チャネルの展望
流通チャネル別に見ると、市場はハイパーマーケット&スーパーマーケット、eコマース、薬局&ドラッグストアに細分化されます。eコマース部門は、2022年の市場で顕著な収益シェアを記録しました。このセグメントの成長は、eコマースの普及により小売eコマースサイトの利用がより便利になったことに起因しています。この動向はさらに、インターネットアクセスが急速に拡大し、オンラインショッピングプラットフォームの人気が高まっていることにも起因しています。さらに、多様な製品の提供や、サポートや情報のための専門的なカスタマーサービス担当者へのアクセスが可能であることも、このセグメントの市場成長にプラスの影響を与えると予想されます。
地域別展望
地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。2022年には、北米地域が市場で最大の収益シェアを獲得しました。これは、ブルートゥース接続やスマートカウントダウン機能などの高度な機能が利用可能なため、排卵検査キットの需要が増加しているためと考えられます。米国には労働者階級が多く、ヘルスケア・プロバイダーを訪れる時間が限られていることが多いため、排卵検査キットの販売台数の増加に寄与しています。この要素は地域市場をさらに強化します。さらに、メーカーは現在、出力の簡便性と信頼性を確保しつつ、より手頃な価格帯で優れた結果を提供できる新製品の開発に注力しています。
The Global Ovulation Testing Kits Market size is expected to reach $3.7 billion by 2030, rising at a market growth of 6.4% CAGR during the forecast period. In the year 2022, the market attained a volume of 5,06,912.7 thousand units, experiencing a growth of 4.8% (2019-2022).
Some advanced ovulation testing kits can connect to smartphones via Bluetooth or wireless. This connectivity enables real-time data transmission and the seamless integration of ovulation data into fertility apps. Therefore, the Digital Ovulation Test segment would acquire approximately 35% share of the market by 2030. Technological advancements have led to the development of smart algorithms that can predict ovulation more accurately based on a user's cycle history. These algorithms consider cycle length, LH surge patterns, and other relevant data points. High-tech ovulation testing kits can connect to Wi-Fi networks, allowing users to securely store and access their ovulation data. This element is particularly appealing to those who prioritize data privacy and security. Some ovulation testing kits offer customization options. Users can input their cycle data, such as cycle length, and receive more tailored predictions, making the kits suitable for a broader range of users. Some of the factors impacting the market are rising proportion of couples adopting delayed parenthood, rising incidence of fertility issues, and growing accuracy concerns regarding test results.
Delaying parenthood often goes hand in hand with increased fertility and reproductive health awareness. Many individuals and couples are well-informed about the potential challenges of conceiving as they age. This awareness has created a need for tools to help them understand and monitor their fertility more effectively. Delayed parenthood has led to a desire to make the most of the remaining fertile years. Ovulation testing kits offer a way to pinpoint the optimal time for conception. The rise in delayed parenthood has led to various educational initiatives and information sharing about fertility, family planning, and the use of ovulation testing kits. Additionally, Fertility issues, such as irregular menstrual cycles, endometriosis, polycystic ovary syndrome (PCOS), and male factor infertility, can make conception challenging. Couples facing these issues often use ovulation testing kits to help them track their fertile window more precisely. Ovulation testing kits are a valuable resource for couples struggling with fertility issues. Identifying the LH surge that precedes ovulation, these kits help couples time their intercourse effectively, increasing the likelihood of conception. The awareness of fertility challenges has led to a proactive approach to fertility management.
One of the most significant effects of the pandemic was a surge in demand for at-home medical products, including ovulation testing kits. With lockdowns and restrictions, many individuals sought to limit their visits to healthcare facilities, clinics, and pharmacies. This led to a higher preference for home-based healthcare solutions, including ovulation testing kits. As a result, the market for these kits experienced a notable boost in sales. On the other hand, for those actively trying to conceive, the heightened importance of maximizing their chances of success during the pandemic led to increased use of ovulation testing kits.
However, inaccurate results, such as false positives (indicating ovulation when it has not occurred) or false negatives (failing to detect an LH surge when it has occurred), can lead to confusion and frustration for users. These inaccuracies can affect family planning efforts and may contribute to consumer skepticism. The quality and consistency of ovulation testing kits can alter between and even within the same brand. Inconsistent results can undermine the reputation of these products and deter repeat purchases. Users may not always follow the instructions correctly, leading to inaccurate results. Manufacturers must address potential user errors by providing clear and detailed instructions. However, ensuring that users consistently follow these instructions remains a challenge.
Product Outlook
On the basis of product, the market is segmented into urine ovulation test, digital ovulation test, and saliva ovulation test. The digital ovulation test garnered a significant revenue share in the market in 2022. The emergence of digital ovulation test kits is anticipated to provide startups with a solid foundation that helps establish their presence in the market. Some digital ovulation tests have built-in memory or smartphone app connectivity, allowing users to track their fertility over time and gain insights into their menstrual cycles. Such features in digital kits are anticipated to increase the demand for these innovative kits. Furthermore, the evolving landscape of healthcare regulations creates favorable conditions for new entrants to gain access to these opportunities.
Distribution Channel Outlook
Based on distribution channel, the market is fragmented into hypermarkets & supermarkets, e-commerce, and pharmacies & drugstores. The e-commerce segment recorded a remarkable revenue share in the market in 2022. The segment's growth is attributed to the prevalence of COVID-19, which has made retail e-commerce websites more convenient to use. This trend is further attributed to the rapid expansion of Internet access and the increasing popularity of online shopping platforms. In addition, the availability of diverse product offerings and access to expert customer service personnel for support and information is expected to influence this segment's market growth positively.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the largest revenue share in the market. This can be attributed to the increasing demand for ovulation test kits due to the availability of advanced features like Bluetooth connectivity and smart countdown functions. The presence of a working-class population in the United States contributes to the increase in unit sales of ovulation test kits, as they often have limited time to visit a healthcare provider. This factor further enhances the regional market. Moreover, manufacturers are currently focusing on developing new products that can deliver superior results at a more affordable price point while ensuring their outputs' simplicity and reliability.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AccuQuik Testkits (AdvaCare Pharma), Fairhaven Health, LLC, Equinox Biotech Co., Ltd., Wondfo Biotech Co., Ltd, Pregmate, SPD Swiss Precision Diagnostics GmbH, Proov, Roman Health Ventures Inc. (Ro), Premom (Easy@Home Fertility), and Piramal Enterprises Limited.
Market Segments covered in the Report:
By Product (Volume, Thousand Units, USD Million, 2019-2030)
By Distribution Channel (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research